Morphological single cell profiling of the epithelial-mesenchymal transition.
暂无分享,去创建一个
Jonathan E Rubins | I. Wong | Susan E Leggett | E. K. Williams | Ian Y Wong | J. Y. Sim | Zachary J. Neronha | Jea Yun Sim | Zachary J Neronha | Evelyn Kendall Williams | Jonathan E. Rubins | Evelyn K Williams | Susan E. Leggett
[1] J. Foidart,et al. Vimentin contributes to human mammary epithelial cell migration. , 1999, Journal of cell science.
[2] Chris Bakal,et al. Molecular Systems Biology Peer Review Process File Cell Shape and the Microenvironment Regulate Nuclear Translocation of Nf-κ B in Breast Epithelial and Tumor Cells Transaction Report , 2022 .
[3] P. Sorger,et al. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.
[4] Jayanta Debnath,et al. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.
[5] J. Burch,et al. High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis , 2008, Molecular Cancer Therapeutics.
[6] H. Kajiyama,et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. , 2007, International journal of oncology.
[7] Kornelia Polyak,et al. Cellular heterogeneity and molecular evolution in cancer. , 2013, Annual review of pathology.
[8] Lani F. Wu,et al. On comparing heterogeneity across biomarkers , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[9] P. Johnston,et al. Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.
[10] Gaudenz Danuser,et al. Computer Vision in Cell Biology , 2011, Cell.
[11] Mehmet Toner,et al. Collective and Individual Migration following the Epithelial-Mesenchymal Transition , 2014, Nature materials.
[12] Anne E Carpenter,et al. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software , 2011, Bioinform..
[13] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[14] Lani F. Wu,et al. Cellular Heterogeneity: Do Differences Make a Difference? , 2010, Cell.
[15] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[16] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[17] P. Sorger,et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.
[18] Stephen T. C. Wong,et al. A Screen for Morphological Complexity Identifies Regulators of Switch-like Transitions between Discrete Cell Shapes , 2013, Nature Cell Biology.
[19] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[20] Jingyu Zhang,et al. TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops , 2014, Science Signaling.
[21] G. Christofori,et al. The relevance of EMT in breast cancer metastasis: Correlation or causality? , 2015, FEBS letters.
[22] P. Sorger,et al. Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology , 2010, Clinical pharmacology and therapeutics.
[23] Andreas Plückthun,et al. Reproducibility: Standardize antibodies used in research , 2015, Nature.
[24] Jeong-Seok Nam,et al. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells , 2015, Oncotarget.
[25] Lani F. Wu,et al. Characterizing heterogeneous cellular responses to perturbations , 2008, Proceedings of the National Academy of Sciences.
[26] Stephen S. Taylor,et al. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. , 2008, Cancer cell.
[27] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[28] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[29] J. Massagué. TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.
[30] G. Moreno-Bueno,et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.
[31] Adrian V. Lee,et al. Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery , 2014, PloS one.
[32] G. Christofori. New signals from the invasive front , 2006, Nature.
[33] M. Hung,et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.
[34] D. Lauffenburger,et al. Measurement and modeling of signaling at the single-cell level. , 2012, Biochemistry.
[35] L. Elia,et al. A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion , 2011, Science Signaling.
[36] P. Jones,et al. Tracking cells in their native habitat: lineage tracing in epithelial neoplasia , 2013, Nature Reviews Cancer.
[37] R. Milo,et al. Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.
[38] Guy S. Salvesen,et al. SnapShot: Caspases , 2011, Cell.
[39] D. Haber,et al. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents , 2010, Nature Reviews Cancer.
[40] Valerie C. Coffman,et al. Counting protein molecules using quantitative fluorescence microscopy. , 2012, Trends in biochemical sciences.
[41] D. Medici,et al. Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.
[42] Wolfgang Link,et al. High content screening: seeing is believing. , 2010, Trends in biotechnology.
[43] Lani F. Wu,et al. Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.
[44] Neil O Carragher,et al. High-Content Phenotypic Profiling of Drug Response Signatures across Distinct Cancer Cells , 2010, Molecular Cancer Therapeutics.
[45] Claire V. Harper,et al. Population robustness arising from cellular heterogeneity , 2010, Proceedings of the National Academy of Sciences.
[46] Polina Golland,et al. Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning , 2009, Proceedings of the National Academy of Sciences.
[47] Sridhar Ramaswamy,et al. Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1 , 2013, Cell reports.
[48] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.